XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
6 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
The following table shows stock-based compensation expense that is included in the consolidated results of operations (in thousands):
Three months ended March 31,Six months ended March 31,
2022202120222021
Cost of sales$131 $89 $217 $171 
Sales and marketing678 623 1,168 1,148 
Research and development317 293 639 503 
General and administrative1,116 1,472 2,235 2,400 
Stock-based compensation before income taxes2,242 2,477 4,259 4,222 
Income tax benefit(470)(541)(900)(906)
Stock-based compensation after income taxes$1,772 $1,936 $3,359 $3,316 
Schedule of Stock Option Activity
The following table summarizes our stock option activity (in thousands, except per common share amounts):
Options OutstandingWeighted Average Exercise PriceWeighted Average Contractual Term (in years)Aggregate Intrinsic Value (1)
Balance at September 30, 20212,952 $13.20
Granted502 22.47
Exercised(1,162)11.43
Forfeited / Canceled(119)16.85
Balance on March 31, 20222,173 $16.354.69$11,887 
Exercisable at March 31, 20221,035 $13.323.46$8,519 
(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, based on our closing stock price of $21.52 as of March 31, 2022, which would have been received by the option holders had all option holders exercised their options as of that date. The intrinsic value of an option is the amount by which the fair value of the underlying stock exceeds its exercise price.
Schedule of Valuation Assumptions
The following table shows the weighted average fair value, which was determined based upon the fair value of each option on the grant date utilizing the Black-Scholes option-pricing model and the related assumptions:
Six months ended March 31,
20222021
Weighted average per option grant date fair value$10.23$7.42
Assumptions used for option grants:
Risk free interest rate1.25% - 1.82%0.51% - 0.66%
Expected term6.00 years6.00 years
Expected volatility45% - 46%44% - 45%
Weighted average volatility46%44%
Expected dividend yield
Schedule of Nonvested Restricted Stock Units
The following table presents a summary of our non-vested restricted stock and performance stock units as of March 31, 2022 and changes during the six months then ended (in thousands, except per common share amounts):
RSUsPSUs
Number of AwardsWeighted Average Grant Date Fair ValueNumber of AwardsWeighted Average Grant Date Fair Value
Nonvested at September 30, 2021812 $15.72 18 $25.15 
Granted334 22.52 — — 
Vested(280)15.60 (3)25.15 
Canceled(84)16.15 — — 
Nonvested at March 31, 2022782 $18.62 15 $25.15